Editas Medicine to Participate in Investor Conferences in June
Tweet
Share
E-mailGet Alerts EDIT Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass., June 13, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in June. Details are as follows:
JMP Securities Life Sciences Conference
| Date: | Tuesday, June 20, 2017 |
| Panel: | Gene Editing - Pushing the Frontier for Curing Disease |
| Time: | 9:00 a.m. ET |
| Location: | New York |
Goldman Sachs Third Annual Innovation Symposium
| Date: | Tuesday, June 27, 2017 |
| Panel: | CRISPR - The Era of Gene Editing |
| Time: | 10:15 a.m. ET |
| Location: | New York |
About Editas MedicineEditas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.
Media Contact Cristi Barnett Editas Medicine, Inc. (617) 401-0113 [email protected] Investor Contact Mark Mullikin Editas Medicine, Inc. (617) 401-9083 [email protected]Source: Editas Medicine
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Buckle, Inc. Announces the Resignation of Angie J. Klein From the Company’s Board of Directors
- Digital Mirror Pioneer YFORE Unveils Full Intelligent Mirror Lineup in North America
- 2026 CIFTIS Environment and Energy Services Section Media Briefing Held
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Goldman Sachs, JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
